Stockscreener 앱 받기
15.19
0.33%
-0.05
시간 외 거래:
15.19
전일 마감가:
$15.24
열려 있는:
$15.27
하루 거래량:
297.87K
Relative Volume:
0.48
시가총액:
$5.35B
수익:
$4.68B
순이익/손실:
$-368.00M
주가수익비율:
-14.47
EPS:
-1.05
순현금흐름:
$-58.00M
1주 성능:
-5.00%
1개월 성능:
-8.71%
6개월 성능:
-2.32%
1년 성능:
-6.06%
1일 변동 폭
$15.07
$15.32
1주일 범위
$15.07
$16.15
52주 변동 폭
$13.16
$21.69
Bausch Lomb Corp Stock (BLCO) Company Profile
명칭
Bausch Lomb Corp
전화
908-541-5456
주소
520 APPLEWOOD CRESCENT, VAUGHAN
BLCO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BLCO
Bausch Lomb Corp
|
15.19 | 5.35B | 4.68B | -368.00M | -58.00M | -1.05 |
|
ISRG
Intuitive Surgical Inc
|
476.78 | 170.05B | 8.35B | 2.32B | 1.30B | 6.41 |
|
BDX
Becton Dickinson Co
|
222.79 | 63.97B | 20.64B | 1.73B | 2.94B | 6.02 |
|
ALC
Alcon Inc
|
86.81 | 42.94B | 9.91B | 1.02B | 665.00M | 2.05 |
|
RMD
Resmed Inc
|
219.72 | 32.28B | 4.93B | 1.25B | 1.38B | 8.47 |
|
BAX
Baxter International Inc
|
34.55 | 17.64B | 17.28B | 108.00M | 391.00M | 0.20 |
Bausch Lomb Corp Stock (BLCO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-11 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2024-12-02 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2024-10-15 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2024-07-10 | 개시 | Raymond James | Outperform |
| 2024-05-06 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2024-01-04 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2023-12-12 | 개시 | Stifel | Hold |
| 2023-10-03 | 재개 | Evercore ISI | Outperform |
| 2023-05-30 | 재개 | Morgan Stanley | Equal-Weight |
| 2023-03-09 | 개시 | Needham | Hold |
| 2022-12-21 | 개시 | Barclays | Equal Weight |
| 2022-09-12 | 개시 | H.C. Wainwright | Buy |
| 2022-07-26 | 개시 | RBC Capital Mkts | Outperform |
| 2022-06-24 | 개시 | Evercore ISI | Outperform |
| 2022-06-06 | 개시 | Citigroup | Buy |
| 2022-05-31 | 개시 | Deutsche Bank | Hold |
| 2022-05-31 | 개시 | Goldman | Neutral |
| 2022-05-31 | 개시 | Guggenheim | Buy |
| 2022-05-31 | 개시 | JP Morgan | Neutral |
| 2022-05-31 | 개시 | Jefferies | Buy |
| 2022-05-31 | 개시 | Morgan Stanley | Equal-Weight |
| 2022-05-31 | 개시 | Wells Fargo | Overweight |
| 2022-05-11 | 개시 | Cowen | Outperform |
모두보기
Bausch Lomb Corp 주식(BLCO)의 최신 뉴스
Nicox Presents New Analysis from the NCX 470 Mont Blanc Trial and Provides Development Update - GlobeNewswire Inc.
HC Wainwright Has Negative View of Bausch + Lomb Q1 Earnings - Defense World
Bausch + Lomb Co. (NYSE:BLCO) Receives Average Rating of “Hold” from Analysts - Defense World
Bank of America Lowers Bausch + Lomb (NYSE:BLCO) Price Target to $17.00 - Defense World
Bausch + Lomb Corporation (NYSE:BLCO) Q4 2024 Earnings Call Transcript - Insider Monkey
Bausch & Lomb Begins to Reap Fruits of Innovation; Broad-Based Growth Fuels Our Long-Term Outlook - Morningstar
Bausch + Lomb Corporation Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2024 - Marketscreener.com
Bausch + Lomb Announces Fourth-Quarter and Full-Year 2024 Results, Provides 2025 Guidance - BioSpace
Bausch + Lomb Corp. Announces FY25 Revenue Within View - Nasdaq
Bausch + Lomb Announces Fourth-Quarter and Full-Year 2024 Results - TradingView
Bausch + Lomb Posts Q4 Revenue of US$1.28 Billion -February 19, 2025 at 06:59 am EST - Marketscreener.com
Short Interest in Bausch + Lomb Co. (NYSE:BLCO) Increases By 37.3% - MarketBeat
Bausch + Lomb (BLCO) Reports Earnings Tomorrow: What To Expect - The Globe and Mail
Bausch + Lomb Sinks After Disclosing It Won’t Go Private Now - Bloomberg
Contact lens maker Bausch + Lomb rules out going private at this time - Reuters
Bausch + Lomb sinks after disclosing it won’t go private now - The Malaysian Reserve
Contact lens maker Bausch + Lomb rules out take-private deal - Yahoo Canada Finance
Bausch + Lomb Provides Update on Potential Sale - Business Wire
Brokerages Set Bausch + Lomb Co. (NYSE:BLCO) Target Price at $20.25 - MarketBeat
Stifel Nicolaus Issues Pessimistic Forecast for Bausch + Lomb (NYSE:BLCO) Stock Price - Defense World
Bausch Health Q4 Results to Focus on 2025 Outlook, Potential Full Separation of Bausch + Lomb, RBC Says - Marketscreener.com
Bausch + Lomb Co. (NYSE:BLCO) Receives Average Recommendation of “Hold” from Brokerages - Defense World
Bausch Lomb Corporation (BLCO-T) QuotePress Release - The Globe and Mail
Bausch + Lomb Corporation - Baystreet.ca
Bausch + Lomb Will Release Fourth-Quarter and Full-Year 2024 Financial Results on February 19 - Business Wire
This Bausch + Lomb Insider Increased Their Holding In The Last Year - Yahoo Finance
Ellsworth Advisors LLC Invests $665,000 in Bausch + Lomb Co. (NYSE:BLCO) - MarketBeat
Wells Fargo & Company Lowers Bausch + Lomb (NYSE:BLCO) Price Target to $24.00 - Defense World
Bausch + Lomb bolsters pipeline with acquisition of Whitecap Biosciences - ROI-NJ.com
Bausch + Lomb Bolsters Pipeline with Acquisition of Whitecap Biosciences - BioSpace
Bausch + Lomb Launches enVista Aspire IOLs in Europe - TipRanks
Intermediate Optimized Monofocal and Toric Intraocular Lenses in the European Union - Business Wire
B%2BL+affiliate+acquires+California-based+pharmaceutical+company+%C2%A0 - Rochester Business Journal
Is Bausch + Lomb (BLCO) the Best Medical Stock to Buy Under $20? - Yahoo Finance
Character Biosciences Announces Collaboration with Bausch + Lomb to Transform Ophthalmology with Precision Medicine - Yahoo Finance
City Therapeutics Announces Strategic Collaboration with Bausch + Lomb to Develop a Novel RNAi-Based Treatment for Geographic Atrophy - Yahoo Finance
Implantable Drug Delivery Devices Business Research Report 2023-2024 & 2030 - GlobeNewswire Inc.
S&P 500 Futures Rise in Premarket Trading; Aurora Innovation, Bausch + Lomb Lead - Barron's
Bausch + Lomb and Glaucoma Research Foundation Launch Second Annual “Faces of Glaucoma” Campaign and Fundraising Challenge - Business Wire
Bausch + Lomb Co. (NYSE:BLCO) Given Consensus Recommendation of “Hold” by Brokerages - Defense World
Bausch + Lomb Co. (NYSE:BLCO) Shares Acquired by State Street Corp - Defense World
Bausch + Lomb to Participate in the 43rd Annual J.P. Morgan Healthcare Conference - Business Wire
Warburg Pincus to buy Bausch & Lomb for $3.67 bln - Reuters
Aesthetic Ophthalmology Devices Business Analysis Report 2024-2030 Featuring 40+ Key Players Including Abbott, Bausch & Lomb, Alcon, Allergan, Carl Zeiss, Haag Streit, Meditec, Topcon, Zeimer - Yahoo Finance
Bausch + Lomb down after report that Blackstone could back away from takeover bid - MSN
BofA rates Bausch & Lomb ‘underperform’ with lower buyout chances - MSN
Y Intercept Hong Kong Ltd Makes New Investment in Bausch + Lomb Co. (NYSE:BLCO) - MarketBeat
Bausch Lomb Corp (BLCO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.47%
0.19%
자본화:
|
볼륨(24시간):